The Clorox Company · Consumer Defensive
The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
Drowns: at a 8.5% margin the price needs +7.8% 3y revenue growth against +6.2% consensus, a -5.2pt cushion versus a 0pt correction cut. Own-execution story; nothing from the AI drop.
Would recover if: The drowns call is wrong if consensus growth rises by more than 5.2pt or the margin proves well above 8.5%.. We re-check this against analyst estimates every evening.
10 years, at a 9% margin analysts expect
+4.7%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
7 published targets, set before the drop
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 124% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 22, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price sits at the 14th percentile of published models, 13% below the median target of $98, meaning the market largely rejects the bull case for recovery and instead prices in continued margin pressure and growth challenges.
Whether Clorox can actually deliver the 13-14% sales growth it forecasts and stabilize gross margins, which can be partially tested by tracking unit volumes but cannot be fully settled because retail pricing data is not wired.
What the price refuses to pay for, and the full reconstruction, on the CLX quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names